DP3 Type 1 Diabetes Targeted Research Award
Research Using Biosamples from Selected Type 1 Diabetes Clinical Studies (DP3)
This Funding Opportunity Announcement (FOA) invites applications for ancillary studies using archived samples from selected diabetes clinical trials and studies. Ancillary studies are expected to generate scientific discoveries on type 1 diabetes primary pathogenesis or the pathogenesis of complications, and biomarkers of disease progression or clinical responses to interventions.
|Notice(s) for this Opportunity|
Information about registering for the informational webinar.
|Letter of Intent Due Date|
|Application Due Date|
November 20, 2014, by 5:00 PM local time of applicant organization.